ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia
about
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to diseaseA point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic protein 1 in lymphopoiesis and innate immunityMndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibilityChemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemiaChronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia.Hem-1: putting the "WAVE" into actin polymerization during an immune response.Machine Learning-based Classification of Diffuse Large B-cell Lymphoma Patients by Their Protein Expression Profiles.Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibodyCTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia.Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNABendamustine therapy in chronic lymphocytic leukemia.Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights.Immune checkpoints and their inhibition in cancer and infectious diseases.Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer.Establishment and characterization of therapy-resistant mantle cell lymphoma cell lines derived from different tissue sites.The Arp2/3 Regulatory System and Its Deregulation in Cancer.Identification of MNDA as a new marker for nodal marginal zone lymphoma.Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer.
P2860
16c548aa001dd8162c09080b5d5fac2caa9bddff256d7aea18ca4856fffd70ef1e2f8ddaf2e2ef932deb480eac749fd0cfd5d3d34b75904eadd92377363a07e5c2659c6f19b5ac87fbd1e78d425eb1ba3e689c3a8797873c6b98dd2068eba72455e94412585ffa6c31df07f8c8bc51f330e3d066c58e985889c6193b8d2bec9b0748786d767fd692450562c7a5355d1e7a953ed362360eb1ce07e615a928f9f7c4534100c906071e8457a67a9a8a9301d204688be4fc722bc1dba3fcd0849dcc855dc884253313b5ebc950c37ebe8e06c844687c07cacf6ba0cc4e96
P248
Q27304652-C3AD4BFC-4BD3-4A0E-901F-4CD9FF4E193EQ28506215-0C04E021-C225-4093-BDF7-E3BB0781D03AQ28593570-21BE1C20-429C-4837-B572-CAE90B0D0CBFQ33382608-95CE0081-7945-41B7-B3FD-BB7F18D502A1Q33934606-1CDD3E11-7225-4957-AF7F-F3E73D0397D3Q34925487-5DF37363-818B-46AE-B8F4-D9D8C06582E4Q35325738-D69D87C6-004A-4295-A3E9-FF86CEFE899FQ35998040-EBFF37F3-9859-4D3B-9807-EE27CAEA5C41Q36263022-0B4D6D8E-ABB7-40C7-978C-DBB50F622144Q36834544-20F531FE-7C4A-497C-AB93-4F1ECA433065Q37143869-378578FF-BB0D-4705-B563-25FD5C30D49DQ37207766-64BDEEC0-2F8B-475D-9B7F-748452BF1227Q37519737-1081B1DC-5E06-493A-9A2E-9037A973D3A6Q38325527-E7493E51-846E-45AD-8315-114A4C0576C5Q38549542-9B8222CF-4BED-45AF-AFD0-23E502B3570DQ38845026-9F73DC8D-46E2-45FB-9B61-D54E0589C167Q39308620-C71AE796-C5FA-4712-A639-434608616EB3Q39352014-1AD76524-2EDD-4ECB-8F9C-DB2164289AD8Q47322418-95856811-A9F7-49AB-946D-35E366D4D21DQ47711249-0EB76602-DF2C-4AFB-AB70-1A7DF7F96173Q53667526-8A7FC704-B777-469A-AC3A-B869ED26594D
P2860
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@ast
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@en
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@en-gb
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@nl
type
label
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@ast
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@en
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@en-gb
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@nl
prefLabel
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@ast
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@en
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@en-gb
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@nl
P2093
P921
P1476
ATM, CTLA4, MNDA, and HEM1 in ...... l chronic lymphocytic leukemia
@en
P2093
Amit K Mittal
Avadhut D Joshi
Ganapati V Hegde
James C Lynch
James D Eudy
John D Dickinson
Marcel P Devetten
Philip J Bierman
R Gregory Bociek
Shantaram S Joshi
P304
P356
10.1158/1078-0432.CCR-07-0283
P407
P433
P577
2007-09-15T00:00:00Z